Cellular Biomedicine (CBMG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 340 | 224 | 337 | 628 | 2,505 |
| Cost of Goods | 62 | 136 | 162 | 860 | 1,880 |
| Gross Profit | 278 | 89 | 175 | -233 | 625 |
| Operating Expenses | 51,332 | 40,730 | 27,913 | 29,043 | 22,354 |
| Operating Income | -50,992 | -40,506 | -27,577 | -28,415 | -20,849 |
| Other Income | 1,009 | 1,565 | 2,089 | 211 | 673 |
| Pre-tax Income | -49,983 | -38,941 | -25,488 | -28,204 | -20,176 |
| Income Tax | 1 | 5 | 3 | -4 | -729 |
| Net Income Continuous | -49,984 | -38,946 | -25,490 | -28,200 | -19,448 |
| Net Income | $-49,984 | $-38,946 | $-25,490 | $-28,200 | $-19,448 |
| EPS Basic Total Ops | -2.63 | -2.20 | -1.78 | -2.09 | -1.70 |
| EPS Basic Continuous Ops | -2.63 | -2.20 | -1.78 | -2.09 | -1.70 |
| EPS Diluted Total Ops | -2.63 | -2.20 | -1.78 | -2.09 | -1.70 |
| EPS Diluted Continuous Ops | -2.63 | -2.20 | -1.78 | -2.09 | -1.70 |
| EPS Diluted Before Non-Recurring Items | -2.63 | -2.04 | -1.78 | -1.88 | -1.70 |
| EBITDA(a) | $-45,354 | $-32,571 | $-24,591 | $-25,780 | $-18,754 |